DreamCIS, Inc. (KOSDAQ:223250)
South Korea · Delayed Price · Currency is KRW 5,150.00
-180.00 (-3.38%)
At close: Mar 12, 2026
DreamCIS Market Cap
DreamCIS has a market cap or net worth of 126.57 billion as of March 13, 2026. Its market cap has increased by 69.11% in one year.
Market Cap
126.57B
Enterprise Value
109.77B
Revenue
62.06B
Ranking
n/a
PE Ratio
6.60
Stock Price
5,150.00
Market Cap Chart
Since May 22, 2020, DreamCIS's market cap has decreased from 165.28B to 126.57B, a decrease of -23.42%. That is a compound annual growth rate of -4.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 126.57B | -16.64% |
| Dec 30, 2025 | 151.84B | 116.27% |
| Dec 30, 2024 | 70.21B | -9.03% |
| Dec 28, 2023 | 77.17B | 25.17% |
| Dec 29, 2022 | 61.65B | -15.87% |
| Dec 30, 2021 | 73.28B | -32.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyundai ADM Bio | 996.69B |
| HLB bioStep | 104.83B |
| P&K Skin Research Center | 62.10B |
| WOOJUNG BIO | 60.08B |
| C&R Research | 47.41B |
| DT&CRO CO. | 40.01B |
| SLS BIO | 26.89B |
| BioInfra | 18.07B |